Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02198131 · ClinicalTrials.gov registry record · NA

Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia

A NA study of Oral Complications of Radiation Therapy and Stage I Laryngeal Cancer, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT02198131 is a NA study of Oral Complications of Radiation Therapy and Stage I Laryngeal Cancer that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 9 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02198131, a NA study of Oral Complications of Radiation Therapy and Stage I Laryngeal Cancer, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This pilot trial studies pulsed dye laser in treating patients with post radiation dysphonia. Dysphonia, or vocal cord scarring, can include trouble with the voice when trying to talk, such as hoarseness, change in voice pitch, and poor voice quality, and it commonly happens after radiation therapy for laryngeal cancer. Pulsed dye laser may improve post radiation dysphonia.

Interventions

  • OTHER questionnaire administration
  • PROCEDURE laser therapy

Study Locations (1)

North Carolina

  • Comprehensive Cancer Center of Wake Forest University - Winston-Salem

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2009-10
Est. Completion 2016-06
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT02198131

The ClinicalTrials.gov registry entry for NCT02198131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Oral Complications of Radiation Therapy appearing as the primary indexed condition, and to 2 interventions - of which questionnaire administration is the first listed.

NCT02198131 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02198131 about?

NCT02198131 is a clinical study titled "Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia". This pilot trial studies pulsed dye laser in treating patients with post radiation dysphonia. Dysphonia, or vocal cord scarring, can include trouble with the voice when trying to talk, such as hoarseness, change in voice pitch, and poor voice quality, and it commonly happens after radiation therapy ...

What is the current status of trial NCT02198131?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2009-10. Estimated completion is 2016-06.

What conditions does trial NCT02198131 study?

This clinical trial studies the following conditions: Oral Complications of Radiation Therapy, Stage I Laryngeal Cancer, Stage II Laryngeal Cancer.

What interventions are being tested in trial NCT02198131?

The interventions under investigation include: questionnaire administration (OTHER), laser therapy (PROCEDURE).

Who is sponsoring clinical trial NCT02198131?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02198131 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.